KUALA LUMPUR: The Health Ministry has been urged to expedite access to a new drug therapy to treat those affected by spinal muscular atrophy (SMA), especially children, said founder of NGO WeCareJourney Yap Sook Yee.
Yee said that SMA is a progressive muscle wasting disease and one of the top genetic killer of babies below the age of two years old.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
